Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
ESC Congress highlights 163 specific topics organised under 9 main topics. For your convenience, most scientific sessions, except satellite symposia, are arranged by topics in themed Villages. No need to walk through the entire congress venue to attend your next favourite scientific session or to meet your peers: the congress layout has been ideally organised in themed Villages to suit your needs and interests.
Rome Auditorium: will cover exclusively the Hot Lines and 2016 ESC Clinical Practice Guidelines sessionsThe “Hub” is the place to visit for live scientific exchange. This is where the Rapid Fire abstract and clinical case sessions, the special tracks such as the ESC Cardiologists of Tomorrow Track, the Day with the Legends, the Meet the Trialists, Guidelines Implementation tracks as well as many other interactive sessions will take place.The Poster Area, divided in the 9 main topics, will feature a moderated poster station and best poster screens to highlight the research posters in each topic. In addition in the poster area, 2 Agoras, will host some Rapid Fire sessions.
Our programme covers the most up-to-date advances in our understanding of cardiovascular disease. For clinical cardiologists, the sessions will offer a concise overview of where we are and where are we going in cardiological sciences, while for basic scientists it will provide a forum for in-depth discussion on the most interesting areas of development.
- Congenital heart disease, epigenetics, heart failure and arrhythmia- Platelets, the microcirculation, exosomes and mitochondria- The present and future of cell therapy and repair- Barriers to cardiac regenerative strategies in acute and chronic myocardial damage- The potential added benefit of tissue engineering
Developmental biologyCardiovascular anatomy and pathologyIntegrative physiology and control mechanismsStem cells and cell therapyGenetics and gene therapy
Metabolism and metabolic syndromesIschaemia and protectionHypertrophy, cell cycle and apoptosisGrowth factors, neurohormones and signal transduction-cardiacExcitation-contraction coupling and contractile remodellingIon channels and electrophysiology Cardiac biology and senescence
AngiogenesisLipidsAtherosclerosisEndothelial function and the microcirculationInflammation, growth factors and signal transduction-vascularVascular remodellingVascular biology, otherPlatelets signaling and function
Our village will combine the latest research with case presentations and interactive discussions to give clear-cut, simple take-home messages for the practising clinician that they can use in their everyday patient care. We will also focus on the Heart Team, expanding discussions over interventions beyond interventional cardiologists and cardiac surgeons to all related professionals, including general cardiologists, general practitioners and endocrinologists, among others.- Blood thinning following transaortic valve implantation- Bystander lesions in ST-segment Elevation Myocardial Infarction (STEMI)- Managing multiple, multi-state diseases- Balance ischaemia management with bleeding risk- Translating recommendations into individual care – the 2015 non-STEMI ESC clinical practice Guidelines
Physiology, haemodynamics and microcirculationInvasive and functional coronary imagingNon-invasive coronary imagingVulnerable plaque
PCI: pre-clinical studiesPCI/stents: devices and techniquePCI: procedural complicationsPCI: primary PCI, patient subsets, otherPCI: long term outcomeNon coronary cardiac interventionsRestenosisRenal denervation
Pathophisiology, epidemiology, diagnosisImaging for peripheral diseaseMedical treatmentPercutaneous/endovascular treatmentStrokeAortic diseaseCarotid disease
Coronary surgeryMitral valve surgeryAortic valve surgeryMinimally invasive and robotic surgeryAorta, peripheral arterial and venous surgeryCirculatory assist and other
Alongside a wide-ranging pharma programme, we focus on challenging aspects of hypertension clinical management. Leading international experts will provide a comprehensive, practical and state-of-the-art overview of the pathophysiology, diagnosis and treatment of hypertension for cardiologists managing this common and important condition in their daily practice. - Hypertension diagnosis and the detection and management of white coat and masked hypertension- Spotting important causes of secondary hypertension- Blood pressure lowering targets in the light of new SPRINT study data- Hypertension and left ventricular hypertrophy as atrial fibrillation and heart failure risk factors, and their management- Debating new and emerging device-based therapies for hypertension
Autonomic nervous system and humoral regulationsHaemodynamics, heart and hypertensionTreatment of hypertensionDevices/interventionsAmbulatory pressure monitoringHypertension: regional and ethnic profilesHypertension, diet, other
Drug therapy, pharmacogenomicsGuidelines and implementation in low resource settings
Managing arrhythmias is one of the challenges of modern cardiology. Our village will feature complex interactive cases and the latest innovations in patient management, at both the atrial and ventricular level. Cardiologists will recognise their own patients, allowing them to evolve their management strategies. We will also highlight novelties in cardiac implantable devices, including the next generation of pacemakers, defibrillators and wearable ICDs.- Challenges in ventricular arrhythmia – Channelopathies and cardiomyopathy- Anticoagulation in special circumstances – Low stroke risk, high bleeding risk- Challenges in ventricular tachycardia – Changing practices and when to ablate- Cardiac implantable devices – The latest novelties- Management strategies – Syncope and atrial fibrillation
Mechanisms of arrhythmiasGenetic aspects of arrhythmiasElectrocardiography/cardioversion/defibrillationNon invasive studies Invasive electrophysiological studiesAtrial fibrillation (AF)Supraventricular arrhythmias (excluding AF)Ventricular arrhythmiasSudden death/resuscitationSyncopeAntiarrhythmic drugsCatheter ablationAntibardycardia pacingAutomatic implantable cardioverter/defibrillatorResynchronisation therapyDevice complications and lead extraction
Our village covers the spectrum of cardiovascular disease, from basic science to practical sessions on patient management and the application of therapies. A special focus will be on the risks associated with procedures, and checklists for intervention delivery. We will also feature a novel and fun Gladiators Arena session “Stable coronary artery disease: stress testing thrown to the lions”, with a focus on issues surrounding interventions and the latest developments.- Management of cardiogenic shock- Clinical situations mimicking acute coronary syndrome - How to handle them?- Non-ST segment Elevation Myocardial Infarction Guidelines in practice- Bridging antithrombotic therapies- Difficult cases in cardio-oncology
Platelets and antiplatelets therapyThrombosis and coagulation Inflammation and immunityMicrocirculation and collaterals
Ischaemia, experimental studiesAngina pectoris stableAngina pectoris unstableInfarction acute phase STEMIInfarction acute phase non STEMIPost infarction periodAdjunctive medical therapyAntithrombotic agents and thrombolysis CAD and comorbidities
CPR (cardiopulmonary resuscitation)Prehospital cardiac care Acute cardiac care in the emergency department Acute intensive cardiovascular care
Imaging is central to the diagnostic pathway of all patients with suspected cardiovascular disease. Our village will emphasise the theme of ESC Congress 2016: the Heart Team. Imaging is at the centre of the Heart Team – without it you cannot diagnose patients and follow-up is more difficult, making it harder to develop the best strategy.- Transcatheter aortic valve implantation – Guiding treatment- Cardiomyopathies – Targeted screening and evaluation with cardiac magnetic resonance- Heart failure with preserved ejection fraction – The latest European Association of Cardiovascular Imaging recommendations- Imaging risk factors – Improving risk stratification and targeting preventative therapies- e-Cardiology – Connecting doctors with patients
Scintigraphy (SPECT)Positron Emission Tomography (PET)Cardiovascular Magnetic Resonance (CMR)X-ray Computed Tomography (CT)Multimodality/hybrid imaging, other imagingHealth economics and comparative effectiveness research
Echo-ventricular function and myocardial diseasesEcho-valvular heart diseaseEcho-contrast/tissue characterisationStress echoEcho/Doppler, other3-D echoPerioperative echo and cardiac interventions
ECG, arrhythmia analysis, signal processingImaging hardware, imaging standards, image processingComputer modelling and simulationRemote patient monitoring and telemedecinem-Health applications and technology assessmente-Cardiology otherBig data analysis in cardiology, registries and databases
Much of cardiovascular disease is preventable and, even when heart
disease develops, the management of risk factors, appropriate treatment
and patient self-management can prevent further events and improve
quality of life. Doing this requires a multi-professional Heart Team
effort to bring together different perspectives, ideas, strengths and
skills in prevention and management, and to address individual and
societal factors affecting cardiovascular disease.- The latest cardiovascular prevention and lipid Guidelines- Tailored exercise prescriptions, latest technologies to change behavior- Is more exercise better or worse?- Stress and long hours, what to eat, smoking cessation and sexual counselling- Pollution, noise and natural disasters
Exercise testing and trainingSports cardiologyPhysical activity
Cardiovascular prevention: interventions and outcomesCardiovascular rehabilitation: interventions and outcomes
Epidemiology, lipidsTobaccoPsycho-social, economic, cultural, occupational diseasesNutrition/obesityEnvironment and CV diseasesPublic health and health policy
Diabetes, dysglycaemia and metabolic syndromeDiabetes managementBodyweight
Acute nursing careChronic nursing carePrimary care
Premature cardiovascular ageingElderly and cardiovascular diseases
Heart failure is common, deadly and extremely costly. There have nevertheless been a number of developments recently in tackling this important disease, and they will be discussed in-depth in our village. New Guidelines on the management of heart failure will also be presented, and there will be several sessions dedicated to discussing important aspects of the Guidelines, as well as to optimising patient outcomes.- Novel Guidelines on acute heart failure- Novel Guidelines on chronic heart failure- Heart failure with preserved ejection fraction- Devices for heart failure- Heart failure drug therapy
Pathophysiology and diagnosisPharmacologic therapyCardiotoxicity of drugsNeurohormonesMedical aspects of transplantationBasic mechanismsCardiac surgeryDiastolic dysfunctionVentricular function/haemodynamicsPeripheral circulation, metabolism and skeletal musclePrognosisHeart failure, other
From basic science to clinical applications in patient management, we will present the latest updates on the most important aspects of valvular disease, pulmonary circulation, myocardial-pericardial disease and adult congenital heart disease. A central part of our programme will be the main theme of the Congress – the Heart Team – alongside novelties within in each of the four topic subgroups.- Latest news on percutaneous valve therapies- Optimal management of patients with valve disease- Hot topics in pulmonary hypertension and pulmonary embolism- An update on cardiomyopathies, myocarditis and pericarditis- Treatment challenges in patients with congenital heart disease
Aortic valve diseaseMitral valve diseaseEndocarditisAortic valve interventionsMitral valve interventionsValvular other and rheumatic diseaseValvular imaging
Acute pulmonary embolismChronic pulmonary hypertensionRight ventricular functionPulmonary circulation, imaging, other
CardiomyopathiesMyocarditisPericardial and myocardial disease, tumours, otherInfectious, parasitic and nutritional diseasesMyocardial-pericardial imaging
Morphology, pathology and geneticsGrown-up congenital heart disease and surgeryCongenital foetal heart disease and interventionCongenital heart disease imagingAdult congenital heart diseasePregnancy and heart diseasePaediatric cardiology, other